Dr Alexandre Akoulitchev
MA (Oxon), PhD (UCL), FRSM

Chief Scientific Advisor

Alexandre (Sasha) is the Chief Scientific Officer and co-founder of Oxford Biodynamics Plc. 

Sasha read mathematics, physics, chemistry, biochemistry and biophysics at the Moscow Institute of Physics and Technology before being selected by the George Soros Foundation in 1989 to study at the University of Oxford. He then obtained his PhD in cell biology from University College London with research based at the Imperial Cancer Research Fund before six years at the Robert Wood Johnson Medical School-UMDNJ in the USA as a research assistant funded by the Howard Hughes Medical Institute. Returning to England, Sasha established his research laboratory at the Sir William Dunn School of Pathology, University of Oxford and was a University Academic Fellow (Research Council UK) and a Senior Fellow of Exeter College, sponsored by Cancer Research UK, Wellcome Trust, Medical Research Council and Monsanto Foundation. Sasha is also a Fellow of the Royal Society of Medicine.

Professor Jane Mellor

PhD

Scientific Advisor

Jane is the Professor of Epigenetics, Department of Biochemistry at Oxford University and is a member of the Scientific Advisory Board at Oxford BioDynamics Plc.  Jane read bacteriology and virology at the University of Manchester and got her PhD from the University of Reading. She started her career as a post-doctoral research scientist at the University of Oxford and then  became a research fellow at Wolfson and Exeter colleges, Oxford University. In 1989, she became the Wellcome Trust senior research fellow in basic biomedical science. Her teaching career started in 1991 and to date she has tutored and supervised more than 20 graduate students gaining their DPhil degrees. Jane has published more than 70 articles in peer reviewed journals and in 2008 was made the first professor of epigenetics at Oxford University. 

Dr Peter Fricker
OAM MBBS FACSEP HonDUniv(Canberra) FRACP(Hon.) FFSEM(Hon.)(UK) GAICD

Chief Medical Advisor

Peter chairs the Medical Commission of the Australian Olympic Committee and the Research Advisory Board for the IOC accredited Australian Collaboration for Research into Injury in Sport and its Prevention at Federation University. 

Peter was the Australian Institute of Sport's first sports physician and went on to serve AIS as Staff Medical Officer, Head of Sports Science and Sports Medicine, Deputy Director and then as Director from 2005-11. Peter has served as medical officer and medical director for Australian teams to six Commonwealth Games (1986-2006) and five Olympic Games (1988-2004), was Chair of the Medical Commission of the Australian Commonwealth Games Association, a member of the Australian Sports Drugs Medical Advisory Committee, a member of the National Anti-doping Research Committee, advisor to the World Anti-doping Agency (WADA) on anti-doping research, and member of the AFL Research Committee.

Dr. Aroul Ramadass

MSc, PHD (CANTAB), PDF (OXON), FCPS, FRAS

Chief Technology Advisor

Aroul is a co-founder of Oxford Biodynamics PLC where he developed the pattern recognition software integral to EpiSwitch™. Prior to the founding of Oxford Biodynamics, Aroul worked together with co-founder, Dr. Alexandre Akoulitchev at the Sir William Dunn School of Pathology, Oxford University.  Aroul read molecular biology and biotechnology at the Indian Agricultural Research Institute, New Delhi, after obtaining National First in the All India Combined Entrance Exam and was awarded the Felix and Cambridge Commonwealth Scholarships to read bioinformatics at Cambridge University and at the Wellcome Trust Sanger Institute (PhD 2004). Aroul is a Fellow of Cambridge Commonwealth Society, Cambridge Philosophical Society and Royal Asiatic Society.

Scott Callender

Founder & CEO

Active in “private equity” for the last 15 years, Scott’s investment philosophy has led to operational involvement in some of his investments. Such has been the genesis of Holos, the creation of which is a partnership with Oxford Biodynamics (OBD), that grew from an investment made in 2007 when OBD’s principals spun-out of Oxford University. Scott’s earlier career included senior positions with listed and non-listed real estate firms, in Australia, Hong Kong, the Philippines, and Singapore. Scott is also the founder of Avila Capital, and is a Board Member of Assetz Property Group. Scott’s studies include BAppSci (Land Economics) at University of Technology, Sydney, and a Diploma in Applied Finance from Macquarie University, Sydney.

Lee Harle

COO

Lee brings hands-on commercial and entrepreneurial experience to Holos, having built both self-funded and VC-backed businesses across the region, including commercialising the Asian operations for AVADO, a UK based, VC backed Ed-tech, focused on digital transformation capabilities for global clients and a partnership with Google. This follows twenty years of blue-chip corporate experience (ICI, OC&C, Pepsico, Diageo) in leadership roles across a range of functions (including CMO, General Manager, Strategy Director) and geographies (including China, Taiwan, Hong Kong, Australia, SE Asia, Japan, USA, Europe, S Africa and Russia). Lee holds an MA in Engineering from Cambridge University and is midway through an MSc in Nutritional Medicine at the University of Surrey.